Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva Settles 16-Year Cipro Pay-For-Delay Litigation For $225M; Will Focus Shift To Pricing Deals?

Jan 28 2017

• By Brenda Sandburg

US dollars

Related Content

Patent Settlements: 2nd Circuit Okays Bayer's Cipro Deal But Doesn't Want To

May 10 2010

FTC Focus On Pay-For-Delay Deals Continues; Endo Agrees To 10-Year Abstention

Jan 25 2017

Teva Settles Provigil Pay-For-Delay Class Action; Will FTC Deal Follow?

Apr 21 2015

Generic Price Fixing Probe: First Charges Unsealed, More May Come Before Inauguration Day

Dec 15 2016

Teva’s Pay-For-Delay Settlement Restricts Brand-Generic Deals

May 29 2015

‘Pay-For-Delay’ Deals Likely Put On Hold Themselves After <em>Cipro</em> Ruling

May 12 2015

Related Companies

Barr Pharmaceuticals

Teva Pharmaceutical Industries Ltd.

Bayer AG

Teva Pharmaceutical Industries Ltd.

Endo, Inc.

Allergan plc

Amneal Pharmaceuticals, Inc.

Cephalon, Inc.

Aurobindo Pharma Limited

Mayne Pharma Group Limited

Viatris Inc.

Additional Topics

United States Generic Drugs Legal Issues Intellectual Property Policy BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window